Key points are not available for this paper at this time.
and its virulence factor FadA may represent a promising therapeutic approach for a portion of UC patients.
Li et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: